Celldex Therapeutics Inc (NASDAQ:CLDX)

0.7001
Delayed Data
As of Apr 20
 +0.021 / +3.09%
Today’s Change
0.65
Today|||52-Week Range
3.42
-75.35%
Year-to-Date

Today’s Trading

Previous close0.68
Today’s open0.69
Day’s range0.69 - 0.75
Volume6,197,051
Average volume (3 months)2,018,751
Market cap$397.8M
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)+43.31%
Earnings growth (this year)-10.91%
Earnings growth (next 5 years)--
Revenue growth (last year)+87.78%
P/E ratioNM
Price/Sales28.65
Price/Book1.65

Competitors

 Today’s
change
Today’s
% change
VCYTVeracyte Inc+0.35+6.07%
OXFDOxford Immunotec Glo...-0.41-3.17%
QTNTQuotient Ltd-0.08-1.78%
TRIBTrinity Biotech PLC+0.11+2.25%
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateMay 3, 2018
EPS forecast (this quarter)-$0.22
Annual revenue (last year)$12.7M
Annual profit (last year)-$93.0M
Net profit margin-730.06%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Anthony S. Marucci
Chief Financial Officer &
Senior Vice President
Sam Martin
Corporate headquarters
Hampton, New Jersey

Forecasts